Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:969-974

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geny, B.
Right arrow Articles by Piquard, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geny, B.
Right arrow Articles by Piquard, F.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Other hypertension
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Hypertension. 1999;33:969-974.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Enhanced Natriuretic Response to Neutral Endopeptidase Inhibition in Heart-Transplant Recipients

Bernard Geny; Hélène Hardy; Jean Lonsdorfer; Bernard Eisenmann; Pascal Haberey; François Piquard

From the Laboratoire des Régulations Physiologiques et des Rythmes Biologiques chez l'Homme et Service de Chirurgie Cardio-Vasculaire, Faculté de Médecine, Strasbourg, France.

Correspondence and reprint requests to Docteur Bernard Geny, Institut de Physiologie, Faculté de Médecine, 67085 Strasbourg Cedex, France. E-mail Francois.Piquard{at}physio-ulp.u-strasbg.fr

Abstract—Heart-transplant recipients (Htx) generally present with body fluid and sodium handling abnormalities and hypertension. To investigate whether neutral endopeptidase inhibition (NEP-I) increases endogenous atrial natriuretic peptide (ANP) and enhances natriuresis and diuresis after heart transplantation, ecadotril was given orally to 8 control subjects and 8 matched Htx, and levels of volume-regulating hormones and renal water, electrolyte, and cyclic guanosine monophosphate (cGMP) excretions were monitored for 210 minutes. Baseline plasma ANP, brain natriuretic peptide (BNP), and cGMP were elevated in Htx, but renin and aldosterone, like urinary parameters, did not differ between groups. NEP-I increased plasma ANP (Htx, 20.6±2.3 to 33.2±5.9 pmol/L, P<0.01; controls, 7.7±1.2 to 10.6±2.6 pmol/L) and cGMP, but not BNP. Renin decreased similarly in both groups, whereas aldosterone decreased significantly only in Htx. Enhanced urinary sodium (1650±370% versus 450±150%, P=0.01), cGMP, and water excretions were observed in Htx and urinary cGMP positively correlated with natriuresis in 6 of the Htx subjects. Consistent with a normal circadian rhythm of blood pressure, without excluding a possible effect of NEP-I, mean systemic blood pressure increased similarly in both groups at the end of the study (6.9±2.0% versus 7.4±2.8% in controls and Htx). Thus, systemic hypertension, mild renal impairment, and raised plasma ANP levels are possible contributory factors in the enhanced natriuresis and diuresis with NEP-I in Htx. These results support a physiological role for the cardiac hormone after heart transplantation and suggest that long-term studies may be useful to determine the potential of NEP-I in the treatment of sodium retention and water retention after heart transplantation.


Key Words: natriuresis • atrial natriuretic peptide • hormones, cardiac • transplantation, cardiac • hypertension




This article has been cited by other articles:


Home page
J. Physiol.Home page
K. Miki, Y. Hayashida, and K. Shiraki
Role of cardiac-renal neural reflex in regulating sodium excretion during water immersion in conscious dogs
J. Physiol., November 15, 2002; 545(1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Piquard, R. Richard, A. Charloux, S. Doutreleau, T. Hannedouche, G. Brandenberger, and B. Geny
Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients
J Appl Physiol, August 1, 2002; 93(2): 569 - 575.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Boomsma and A. H. van den Meiracker
Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
Cardiovasc Res, August 15, 2001; 51(3): 442 - 449.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Geny, R. Richard, B. Mettauer, J. Lonsdorfer, and F. Piquard
Cardiac natriuretic peptides during exercise and training after heart transplantation
Cardiovasc Res, August 15, 2001; 51(3): 521 - 528.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Piquard, A. Charloux, B. Mettauer, E. Epailly, E. Lonsdorfer, S. Popescu, J. Lonsdorfer, and B. Geny
Exercise-Induced Increase in Circulating Adrenomedullin Is Related to Mean Blood Pressure in Heart Transplant Recipients
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2828 - 2831.
[Abstract] [Full Text]